Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.33
Delayed Data
As of May 22
 -0.33 / -3.10%
Today’s Change
8.84
Today|||52-Week Range
18.48
-27.00%
Year-to-Date

Today’s Trading

Previous close10.66
Today’s open10.69
Day’s range10.22 - 10.75
Volume1,054,282
Average volume (3 months)1,801,830
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+22.85%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book13.03

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.45+2.56%
NXTMNxStage Medical Inc-0.14-0.83%
DBVTDBV Technologies SA-0.43-1.71%
BRLIBio-Reference Labora...-0.41-1.21%
Data as of 4:14pm ET, 05/22/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers